Loading quotes...

Forecast

Buy	1
Hold	2
Sell	0

News Go to news feed

Charlotte’s Web appoints Jeff Raborn to board of directors

Charlotte’s Web has appointed Jeff Raborn, Executive Vice President Law & External Affairs and General Counsel at Reynolds American (a BAT subsidiary), to its board effective May 28. The nomination was made by BT DE Investments, a subsidiary of British American Tobacco, as part of an agreed transaction and increases the board to seven members. Raborn brings extensive experience in law, regulation and corporate governance for highly regulated consumer goods industries, strengthening the company amid an increasingly dynamic regulatory environment. » More on de.investing.com
Charlotte's Web Holdings: Q2 2025 revenue beats expectations, stock remains steady

Charlotte's Web Holdings Inc. reported Q2 2025 revenue of $12.8 million, beating expectations, while EPS of -$0.04 missed estimates. The net loss narrowed significantly and the stock was steady in premarket trading; management is targeting positive cash flow by 2026. Product innovations and expanded distribution channels are expected to support further growth. » More on de.investing.com
Charlotte’s Web grants $750,000 loan to DeFloria joint venture

Charlotte’s Web Holdings has provided a $750,000 loan to the joint venture DeFloria Inc., which was established together with AJNA BioSciences and a subsidiary of British American Tobacco. The loan is due by the end of 2026 at the latest or upon a larger financing round, with Charlotte’s Web entitled to exercise contractual rights in the event of default. No further financial details were disclosed in the publicly available portion of the SEC filing. » More on de.investing.com

Financials

In the last quarter, CHARLOTTES WEB HLDGS had revenue of €9.51m and net profit of -€3.62m

(EUR)	June 2026	YoY
Revenue	9.51m	12.46%
Gross profit	4.52m	11.09%
Net profit	-3.62m	32.22%
EBITDA	-2.51m	16.89%

Fundamentals

Metric	Value
Market capitalization	€54.47m
Number of shares	271.29m
52-week high/low	€0.87 - €0.0669
Dividends	No
Beta	2.27
P/E ratio	-1.06
PEG ratio	0.02
P/B ratio	0.64
P/S ratio	1.30

Company profile

Charlotte's Web Holdings, Inc. engages in farming, manufacturing, marketing, and selling hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies comprising sleep, stress, immunity, and exercise recovery products; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Denver, Colorado.